APD-916

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAPD-916
Drug Alias NameAPD-916
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor inverse agonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsSleepiness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArena Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSleepiness

Other Information

ATC CodeN/A
Related LinksN/A